Inhibition of complement components C3 and C4 by cadralazine and its active metabolite-Reference-Cited by-同舟云学术

Inhibition of complement components C3 and C4 by cadralazine and its active metabolite

Published:1991-03 Issue:3 Volume:40 Page:261-265
ISSN:0031-6970
Container-title:European Journal of Clinical Pharmacology
language:en
Short-container-title:Eur J Clin Pharmacol

Author:

Andersson M.,Hanson A.,Englund G.,Dahlb�ck B.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/BF00315206.pdf

Reference18 articles.

1. Andersson OK (1987) Cadralazine did not produce the SLE-Syndrome when hydralazine did. Eur J Clin Pharmacol 31: 741

2. Carpi C, Dorigotti L, Semeraro C (1981) Cadralazine and its identified metabolites: comparative effects on blood pressure and on arterial smooth muscle. Br J Clin Pharmacol 72: 188?189

3. Dahlbäck B, Hildebrand B (1983) Degradation of human complement component C4b in the presence of the C4b-binding protein ? protein S complex. Biochem J 209: 857?863

4. Evans DAP (1968) Genetic variation in acetylation of isoniazid and other drugs. Ann NY Acad Sci 151: 723?733

5. Haglund K, Dahlqvist R, Emilsson H, Englund G (1988) Cadralazine Pharmacokinetics-A Pilot Study. Eur J Clin Pharmacol 35: 571?572

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NC4 Domain of Cartilage-specific Collagen IX Inhibits Complement Directly Due to Attenuation of Membrane Attack Formation and Indirectly through Binding and Enhancing Activity of Complement Inhibitors C4B-binding Protein and Factor H;Journal of Biological Chemistry;2011-08

2. Isolation, synthesis and complement inhibiting activity of the naturally occurring K-76, its analogues and derivatives;Arkivoc;2011-01-29

3. C1q inhibits immune complex-induced interferon-α production in plasmacytoid dendritic cells: A novel link between C1q deficiency and systemic lupus erythematosus pathogenesis;Arthritis & Rheumatism;2009-10

4. Artificial inhibition of the complement system;Russian Journal of Bioorganic Chemistry;2007-09

5. Separation of decay-accelerating and cofactor functional activities of Kaposi's sarcoma-associated herpesvirus complement control protein using monoclonal antibodies;Immunology;2007-08-30